Chemical Compound

(4S,7S,10S,13R,16S,19S)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate

CAS Registry Number 108736-35-2
返回搜索 申请报价
(4S,7S,10S,13R,16S,19S)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate 结构式
Primary record

(4S,7S,10S,13R,16S,19S)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate

库存
1,403 克
纯度
99.7 %
CAS
108736-35-2

化合物标识与属性

CAS
108736-35-2
PubChem CID
71349
SMILES
CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N
Canonical SMILES
CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccc3ccccc3c2)CSSCC(C(=O)NC(C(N)=O)C(C)O)NC1=O

名称与同义词

  • Lanreotide
  • Lanreotide acetate
  • Angiopeptin
  • Somatuline
  • Somatulin
  • Autogel
  • Lanreotida
  • Lanreotidum
  • Ipstyl
  • Lanreotide Autogel
  • Somatuline Depot
  • Somatulin-Autogel
  • Somatuline Autogel
  • Angiopeptin acetate
  • Lanreotide acetate?
  • Somatuline lp (TN)
  • Lanreotide [INN:BAN]
  • Lanreotide acetate salt
  • Lanreotidum [INN-Latin]
  • Lanreotida [INN-Spanish]
  • AC1L2FZT
  • Somatuline Depot Injection
  • 108736-35-2
  • D0M2YE
  • D0V1SB
  • UNII-IEU56G3J9C
  • Lanreotide acetate [USAN]
  • Bim-23014
  • 127984-74-1
  • C54H69N11O10S2
  • UNII-0G3DE8943Y
  • BIM 23014
  • GTPL2031
  • SCHEMBL14802383
  • SCHEMBL29381700
  • CTK8G7572
  • PUDHBTGHUJUUFI-UHFFFAOYSA-N
  • BDBM627974
  • BIM 23014C
  • BIM-23014C
  • HMS5086G18
  • CFA98474
  • CID71349
  • DC 13-116
  • EBC-27524
  • EX-A16598
  • MFCD00873576
  • DB06791
  • C54H69N11O10S2.xC2H4O2
  • CVD-0019446
  • Somatuline; Lanreotidum; BIM 23014C
  • Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2
  • NCGC00181321-01
  • AC-38355
  • AK608077
  • AN-33681
  • BS-42393
  • DA-54783
  • DA-54784
  • C54-H69-N11-O10-S2
  • LS-153748
  • LS-172394
  • 10-(4-Aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide
  • 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • 33928-EP2272827A1
  • 33928-EP2275420A1
  • 33928-EP2295055A2
  • 33928-EP2295416A2
  • 33928-EP2295426A1
  • 33928-EP2295427A1
  • 33928-EP2298748A2
  • 33928-EP2298764A1
  • 33928-EP2298765A1
  • 33928-EP2305642A2
  • 33928-EP2311453A1
  • 33928-EP2311808A1
  • 33928-EP2311829A1
  • EN300-26911522
  • L000343
  • C54-H69-N11-O10-S2.x-C2-H4-O2
  • 10-(4-aminobutyl)-19-[[2-amino-3-(2-naphthyl)propanoyl]amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • |A-(2-Naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr amide [Disulfide Bridge: 2 C7]
  • (4S,7S,10S,13R,16S,19S)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate
  • 2-({19-[2-amino-3-(naphthalen-2-yl)propanamido]-10-(4-aminobutyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide
  • 2378114-72-6
  • 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2 inverted exclamation marku7)-disulfide acetate
  • 3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-->7)-disulfide
  • 3-(2-Naphthyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide, cyclic (2->7)-disulfide, acetate (salt)
  • L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
  • L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
  • Lanreotide; Angiopeptin; 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide; 127984-74-1